Leland Stanford Junior University

Stanford, California 94305-5407

3 studies enrolling now · 11 studies all time

What they study most

Aneurysm Dissecting, Aneurysm Thoracic, Aneurysm of Aortic Arch, Aorta, Lesion, Aorta; Lesion, Aortic Aneurysm, Abdominal, Aortic Aneurysm, Thoracic, Congenital Heart Disease, Congenital Heart Disease (CHD), Cutaneous T-Cell Lymphoma, Dissection, Dissection Aortic Aneurysm

Studies at this site

• Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network — Recruiting now
• Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance — Recruiting now
• Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study — Recruiting now
• Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia — Running, not enrolling
• Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2 — Running, not enrolling
• Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms — Running, not enrolling
• Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1 — Running, not enrolling
• A Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia — Completed
• Early Feasibility of the Branched TAG® Device in the Treatment of Aortic Arch Aneurysms — Completed
• Feasibility Study for GORE® TAG® Thoracic Branch Endoprosthesis to Treat Proximal Descending Thoracic Aortic Aneurysms — Completed
• A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas — Stopped early